Supporting growth of London-based pharmaceutical company

eAwazMedicine

ANVO Laboratories to receive $4-million investment to create 45 skilled jobs and strengthen Canada’s biomanufacturing production capacity London – Advancements in pharmaceuticals support the health of Canadians, as well as the success of our economy. With a growing manufacturing sector, strong healthcare, post-secondary network, and an ideal location between the U.S. border, Windsor, and Toronto, the London region is well …

9 J&J Innovations That Helped Drive Medicine Forward

eAwazMedicine

London – From its earliest days, Johnson & Johnson has been committed to innovation and driving medical advancements forward. That cutting-edge work might include reinventing or refining existing medical tools, systems and machinery to make them perform stronger and better. Or it could be about taking an entirely new approach to treating a disease or condition that ends up promoting …

Ontario Building Modern Facilities at Timmins & District Hospital

eAwazMedicine

Investments in critical upgrades and repairs connecting Ontarians to care, closer to home TIMMINS — The Ontario government is investing $2 million this year through the Health Infrastructure Renewal Fund to help Timmins and District Hospital complete critical upgrades and repairs that will create a safer, more comfortable space for people and their families connecting to care and services at …

Miracle drug for tooth regeneration to be put on trial

eAwazMedicine

Japan – A team of researchers in Japan is currently working on a medicine that can potentially grow a new set of teeth and is set for a medical trial in July 2024, Japan’s daily news site, the Mainichi reported. Dr Katsu Takahashi, a lead researcher and head of the dentistry and oral surgery department at the Medical Research Institute …

Accelerating, Strengthening Global Response to Synthetic Drugs

eAwazMedicine

Ottawa – We the Ministers and government representatives of the undersigned States, having met virtually on 7 July 2023, affirm our shared commitment to taking concerted and sustained action at the national, regional, and international levels to effectively respond to emerging drug-related threats in an integrated and balanced manner. We express grave concern about the public health and social harms …

Convening, connecting nurses from all over world

eAwazMedicine

Ottawa – Prime Minister Justin Trudeau was at the ICN Congress that includes the Opening ceremony and Exhibition opening! It is convening and connecting nurses from all over the world! Trudeau said: “No one has their finger on the pulse of our health care system as much as nurses do. When I spent time with ICN and Canada Nurses today, …

Additional research funding given to help people in Canada sleep well

eAwazMedicine

Ottawa – Sleep is a crucial part of overall health, playing an important role in physical and mental health. Not getting enough sleep can contribute to health issues, including cardiovascular disease, diabetes, hypertension, infection or sepsis, cancer, poor mental health, and premature death. While half of all adults in Canada have trouble sleeping, research shows that racial discrimination can make …

Janssen Announces Positive Topline Results for JNJ-2113

eAwazMedicine

PENNSYLVANIA – The Janssen Pharmaceutical Companies of Johnson & Johnson announced positive topline results from its Phase 2b FRONTIER 1 clinical trial evaluating the novel, first and only oral interleukin-23 receptor (IL-23R) antagonist peptide JNJ-2113 in adult patients with moderate-to-severe plaque psoriasis (PsO).1 The trial achieved all primary and secondary efficacy endpoints. A greater proportion of patients who received JNJ-2113 achieved …

US Moderna coronavirus vaccine

MODERNA INITIATES ROLLING SUBMISSION TO HEALTH CANADA FOR UPDATED COVID-19 VACCINE

eAwazMedicine

TORONTO – Moderna, Inc, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, has  announced that it has initiated the filing of a rolling New Drug Submission (NDS) to Health Canada for its updated monovalent COVID-19 vaccine, SPIKEVAX® XBB.1.5 (mRNA1273.815) targeting the omicron subvariant XBB.1.5 of SARS-CoV-2. This follows Moderna’s submission to the U.S. Food and Drug Administration for …

Australia 2st nation to prescribe psychedelics for depression

eAwazMedicine

SYDNEY –  Australia has become the first country to allow psychiatrists to prescribe certain psychedelic substances to patients with depression or post-traumatic stress disorder. The doctors there can now prescribe MDMA, called ecstasy also, for PTSD. Psilocybin, the psychoactive ingredient in psychedelic mushrooms, can be given to people who have hard-to-treat depression.